Psilera, atai Life Sciences Announce Licensing Agreement for DMT-Patent Portfolio

March 4, 2025

American Journal of Psychiatry Devotes Entire Issue to Psychedelics

January 7, 2025

Massachusetts Psychedelic Legalization Initiative Advances to Ballot

July 11, 2024

Clearmind Medicine Submits Three Patent Applications for Psychedelic Drugs

February 21, 2024

Cybin Granted 2 Additional Patents in Japan for DMT

February 9, 2024

Cybin Receives FDA Clearance to Initiate Phase 2a Study of DMT Molecule for Anxiety

January 24, 2024